Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local

Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cuchacovich T,Miguel, Pacheco B,Patricio, Merino B,Guillermo, Gallardo V,Patricia, Gatica R,Héctor, Valenzuela H,Hernán, Verdaguer D,Juan, Verdaguer T,Juan
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2000
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872000001100004
record_format dspace
spelling oai:scielo:S0034-988720000011000042001-01-29Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento localCuchacovich T,MiguelPacheco B,PatricioMerino B,GuillermoGallardo V,PatriciaGatica R,HéctorValenzuela H,HernánVerdaguer D,JuanVerdaguer T,Juan Arthritis rheumatoid Epiescleritis Scleral diseases Scleritis Sjögren syndrome Vasculitis Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis. Patients and methods: Forty six patients with refractory scleritis and episcleritis were studied and treated during the period 1991 to 1998. Results: Necrotizing type was the most common and severe category in the scleritis group of patients. A decrease in vision occurred in 58.3% of patients with scleritis v/s a 23.5% of patients with epiescleritis (p<0,05). Uveitis was present in 35.4% of patients with scleritis and scleromalacia was present in 33.3% (p<0,05). A specific disease association was uncovered in 51% of scleritis and in 38% of episcleritis patients. Rheumatoid arthritis, primary systemic vasculitic disease and Sjögren syndrome with vasculitis were the most common associated systemic diseases. Three patients with scleritis had tuberculosis. Conclusions: Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information. A meticulous approach for the detection of a specific associated disease must be undertaken. Scleritis associated with vasculitis has a worse ocular prognosis than other non infectious diseases. Cyclophosphamide is the most effective inmunosuppresive treatment to control severe ocular involvement (Rev Méd Chile 2000; 128: 1205-14)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.11 20002000-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004es10.4067/S0034-98872000001100004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Arthritis rheumatoid
Epiescleritis
Scleral diseases
Scleritis
Sjögren syndrome
Vasculitis
spellingShingle Arthritis rheumatoid
Epiescleritis
Scleral diseases
Scleritis
Sjögren syndrome
Vasculitis
Cuchacovich T,Miguel
Pacheco B,Patricio
Merino B,Guillermo
Gallardo V,Patricia
Gatica R,Héctor
Valenzuela H,Hernán
Verdaguer D,Juan
Verdaguer T,Juan
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
description Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis. Patients and methods: Forty six patients with refractory scleritis and episcleritis were studied and treated during the period 1991 to 1998. Results: Necrotizing type was the most common and severe category in the scleritis group of patients. A decrease in vision occurred in 58.3% of patients with scleritis v/s a 23.5% of patients with epiescleritis (p<0,05). Uveitis was present in 35.4% of patients with scleritis and scleromalacia was present in 33.3% (p<0,05). A specific disease association was uncovered in 51% of scleritis and in 38% of episcleritis patients. Rheumatoid arthritis, primary systemic vasculitic disease and Sjögren syndrome with vasculitis were the most common associated systemic diseases. Three patients with scleritis had tuberculosis. Conclusions: Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information. A meticulous approach for the detection of a specific associated disease must be undertaken. Scleritis associated with vasculitis has a worse ocular prognosis than other non infectious diseases. Cyclophosphamide is the most effective inmunosuppresive treatment to control severe ocular involvement (Rev Méd Chile 2000; 128: 1205-14)
author Cuchacovich T,Miguel
Pacheco B,Patricio
Merino B,Guillermo
Gallardo V,Patricia
Gatica R,Héctor
Valenzuela H,Hernán
Verdaguer D,Juan
Verdaguer T,Juan
author_facet Cuchacovich T,Miguel
Pacheco B,Patricio
Merino B,Guillermo
Gallardo V,Patricia
Gatica R,Héctor
Valenzuela H,Hernán
Verdaguer D,Juan
Verdaguer T,Juan
author_sort Cuchacovich T,Miguel
title Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
title_short Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
title_full Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
title_fullStr Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
title_full_unstemmed Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
title_sort características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
publisher Sociedad Médica de Santiago
publishDate 2000
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004
work_keys_str_mv AT cuchacovichtmiguel caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT pachecobpatricio caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT merinobguillermo caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT gallardovpatricia caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT gaticarhector caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT valenzuelahhernan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT verdaguerdjuan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
AT verdaguertjuan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal
_version_ 1718435943510179840